Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:55 pm Purchase |
2023-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Lincoln Park Capital Fund LLC | 260,731 9.990% |
251,618 (+2761.26%) |
Filing History |
| 2024-02-14 4:32 pm Sale |
2023-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Lincoln Park Capital Fund LLC | 1,600,136 0.947% |
-209,951 (-11.60%) |
Filing History |
| 2024-02-14 4:31 pm Sale |
2023-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Lincoln Park Capital Fund LLC | 5,841 0.375% |
-112,650 (-95.07%) |
Filing History |
| 2024-02-14 4:31 pm Sale |
2023-12-31 | 13G | Ensysce Biosciences, Inc. ENSC |
Lincoln Park Capital Fund LLC | 8,267 3.792% |
-72 (-0.86%) |
Filing History |
| 2024-02-14 4:30 pm Sale |
2023-12-31 | 13G | Windtree Therapeutics, Inc. WINT |
Lincoln Park Capital Fund LLC | 377 6.181% |
-133 (-26.11%) |
Filing History |
| 2024-02-14 4:29 pm Purchase |
2023-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Lincoln Park Capital Fund LLC | 1,307,049 9.676% |
369,461 (+39.41%) |
Filing History |
| 2023-06-02 4:46 pm Purchase |
2023-05-31 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Lincoln Park Capital Fund LLC | 118,491 8.980% |
118,491 (New Position) |
Filing History |
| 2023-04-24 4:33 pm Purchase |
2023-04-20 | 13G | Windtree Therapeutics, Inc. WINT |
Lincoln Park Capital Fund LLC | 510 9.990% |
510 (New Position) |
Filing History |
| 2023-02-06 6:34 pm Purchase |
2023-02-02 | 13G | Ensysce Biosciences, Inc. ENSC |
Lincoln Park Capital Fund LLC | 8,339 9.990% |
8,339 (New Position) |
Filing History |
| 2022-10-25 06:01 am Purchase |
2022-10-21 | 13G | Cellectar Biosciences, Inc. CLRB |
Lincoln Park Capital Fund LLC | 937,588 9.990% |
706,220 (+305.24%) |
Filing History |
| 2022-07-28 5:09 pm Purchase |
2022-07-26 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Lincoln Park Capital Fund LLC | 9,112 9.990% |
9,112 (New Position) |
Filing History |
| 2022-05-18 12:34 pm Purchase |
2022-05-17 | 13G | Vallon Pharmaceuticals, Inc. VLON |
Lincoln Park Capital Fund LLC | 35,008 9.990% |
35,008 (New Position) |
Filing History |
| 2022-04-27 10:52 am Purchase |
2022-04-22 | 13G | Salarius Pharmaceuticals, Inc. SLRX |
Lincoln Park Capital Fund LLC | 14,849 5.980% |
14,849 (New Position) |
Filing History |
| 2022-01-19 11:05 am Purchase |
2022-01-14 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Lincoln Park Capital Fund LLC | 1,810,087 6.440% |
1,810,087 (New Position) |
Filing History |
| 2021-11-19 12:57 pm Purchase |
2021-11-12 | 13G | Nabriva Therapeutics plc NBRVF |
Lincoln Park Capital Fund LLC | 180,504 7.960% |
180,504 (New Position) |
Filing History |
| 2021-04-28 5:22 pm Purchase |
2021-04-28 | 13G | Benitec Biopharma Inc. BNTC |
Lincoln Park Capital Fund LLC | 24,913 5.392% |
24,913 (New Position) |
Filing History |
| 2021-01-15 6:21 pm Purchase |
2021-01-14 | 13G | Viveve Medical, Inc. VIVE |
Lincoln Park Capital Fund LLC | 701,000 9.990% |
701,000 (New Position) |
Filing History |
| 2021-01-08 4:38 pm Purchase |
2021-01-07 | 13G | Onconova Therapeutics, Inc. ONTX |
Lincoln Park Capital Fund LLC | 909,294 6.520% |
909,294 (New Position) |
Filing History |
| 2020-11-13 06:01 am Purchase |
2020-11-12 | 13G | Moleculin Biotech, Inc. MBRX |
Lincoln Park Capital Fund LLC | 53,192 7.520% |
53,192 (New Position) |
Filing History |
| 2020-08-03 4:03 pm Purchase |
2020-08-03 | 13G | Advaxis, Inc. ADXS |
Lincoln Park Capital Fund LLC | 57,435 6.940% |
57,435 (New Position) |
Filing History |